Ontramab 150mg Injection
Marketer
Celon Laboratories Ltd
Salt Composition
Trastuzumab (150mg)
Overview Ontramab 150mg Injection
Herceptin-like Ontramab 150mg injection combats breast and gastric cancers by targeting and eliminating HER2-positive cells. Administered intravenously by a healthcare professional, the dosage and frequency are individualized based on your condition and may adjust over time. Strictly adhere to your physician's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under medical supervision. Common side effects include nausea, headaches, skin rashes, sleep disturbances, and increased infection risk. Ontramab can lower blood cell counts, raising infection vulnerability; regular blood tests monitoring blood cell levels, cardiac function, hepatic status, and uric acid are crucial. Report shortness of breath, cough, chills, or limb swelling immediately. Inform your doctor of all other medications you are taking, as interactions are possible. Avoid pregnancy during treatment; effective contraception is essential for both partners.
Primary Ingredients of Ontramab 150mg Injection
No information provided. Please provide the text you want me to rewrite.
Uses of Ontramab 150mg Injection
Cancers affecting the breast and stomach.
Major Benefits of Ontramab 150mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Ontramab 150mg Injection:
- Anemia (low number of red blood cells)
- Chills
- Common cold
- Cough
- Decreased blood cells (red cells, white cells, and platelets)
- Diarrhea
- Fatigue
- Fever
- Headache
- Heart failure
- Infection
- Insomnia (difficulty in sleeping)
- Mucosal inflammation
- Nausea
- Rash
- Stomatitis (Inflammation of the mouth)
- Taste change
- Upper respiratory tract infection
- Weight loss
How to use Ontramab 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Ontramab 150mg Injection works:
The injectable medication Ontramab (150mg) is a genetically engineered monoclonal antibody of the IgG1 class. Its mechanism involves targeting and binding to HER2 receptors, human epidermal growth factor receptor proteins known to drive excessive cell growth in breast and gastric cancers. This binding disrupts HER2 activity, leading to cancer cell destruction and the suppression of associated oncogenic signaling cascades.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Ontramab 150mg Injection and alcohol may lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Administering Ontramab 150mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might consider its use if the potential advantages outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
The use of Ontramab 150mg Injection while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Ontramab 150mg Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The use of Ontramab 150mg Injection in individuals with kidney impairment appears to present a low risk. Current evidence indicates that dose modification for Ontramab 150mg Injection may be unnecessary in such cases. However, medical advice should always be sought.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ontramab 150mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Ontramab 150mg Injection :
Should you forget a scheduled dose of Ontramab 150mg Injection, seek medical advice from your physician.
Facts to Know About Ontramab 150mg Injection
| Label | Value |
|---|---|
| Chemical Type | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Action Category | Monoclonal Antibody HER2/neu (ErbB2) Inhibitor |
3,018 People bought this recently